Matches in Wikidata for { <http://www.wikidata.org/entity/Q89243309> ?p ?o ?g. }
Showing items 1 to 46 of
46
with 100 items per page.
- Q89243309 description "artículu científicu espublizáu n'ochobre de 2014" @default.
- Q89243309 description "im Oktober 2014 veröffentlichter wissenschaftlicher Artikel" @default.
- Q89243309 description "scientific article published on 26 October 2014" @default.
- Q89243309 description "wetenschappelijk artikel" @default.
- Q89243309 description "наукова стаття, опублікована в жовтні 2014" @default.
- Q89243309 name "Cost-Effectiveness Analysis of Bevacizumab, Fotemustine and Extended-Dose Temozolomide in Patients with Recurrent Glioblastoma in Spain" @default.
- Q89243309 name "Cost-Effectiveness Analysis of Bevacizumab, Fotemustine and Extended-Dose Temozolomide in Patients with Recurrent Glioblastoma in Spain" @default.
- Q89243309 type Item @default.
- Q89243309 label "Cost-Effectiveness Analysis of Bevacizumab, Fotemustine and Extended-Dose Temozolomide in Patients with Recurrent Glioblastoma in Spain" @default.
- Q89243309 label "Cost-Effectiveness Analysis of Bevacizumab, Fotemustine and Extended-Dose Temozolomide in Patients with Recurrent Glioblastoma in Spain" @default.
- Q89243309 prefLabel "Cost-Effectiveness Analysis of Bevacizumab, Fotemustine and Extended-Dose Temozolomide in Patients with Recurrent Glioblastoma in Spain" @default.
- Q89243309 prefLabel "Cost-Effectiveness Analysis of Bevacizumab, Fotemustine and Extended-Dose Temozolomide in Patients with Recurrent Glioblastoma in Spain" @default.
- Q89243309 P1433 Q89243309-3FEC224A-0AD5-423A-B05E-36EBEF8B8B47 @default.
- Q89243309 P1476 Q89243309-D26AC5F7-06BF-49CB-B83D-4D7283C6B5FF @default.
- Q89243309 P2093 Q89243309-2A30161A-8481-4811-8C28-D38D909E6828 @default.
- Q89243309 P2093 Q89243309-6A332161-1F74-49E3-9548-F5429D5CB990 @default.
- Q89243309 P2093 Q89243309-CB6FCFDD-90B7-4B1E-B3F5-434064D28DA9 @default.
- Q89243309 P2093 Q89243309-ED989446-AFEF-4408-90EA-BD3DDEADA265 @default.
- Q89243309 P304 Q89243309-4C8B5A68-FA99-453C-B235-4F6AF661F5FA @default.
- Q89243309 P31 Q89243309-EACBAF2A-3A6E-4651-B88E-72D796DBA449 @default.
- Q89243309 P356 Q89243309-951D0017-A447-49D5-BB4C-E528E01A7A6D @default.
- Q89243309 P433 Q89243309-0285B01E-7F4E-409D-9132-0B4F8D43C0B4 @default.
- Q89243309 P478 Q89243309-1CE94E71-DC54-481B-AEF9-670101F7D39B @default.
- Q89243309 P577 Q89243309-E203A0D9-DC21-462D-A422-A5B6A01A5D7B @default.
- Q89243309 P698 Q89243309-AAD3C6C0-C70F-419D-B3D5-421D31E0420D @default.
- Q89243309 P921 Q89243309-707390D1-DA25-498C-849E-5D281881988C @default.
- Q89243309 P921 Q89243309-A0F2076B-B22D-4844-B7C7-AD820EC802AE @default.
- Q89243309 P921 Q89243309-C3AB4218-672A-4A0D-BCF5-964437971260 @default.
- Q89243309 P356 J.JVAL.2014.08.2298 @default.
- Q89243309 P698 27202279 @default.
- Q89243309 P1433 Q15766908 @default.
- Q89243309 P1476 "Cost-Effectiveness Analysis of Bevacizumab, Fotemustine and Extended-Dose Temozolomide in Patients with Recurrent Glioblastoma in Spain" @default.
- Q89243309 P2093 "Barrios J M Rodriguez" @default.
- Q89243309 P2093 "J L Garcia Lopez" @default.
- Q89243309 P2093 "J Puig-Junoy" @default.
- Q89243309 P2093 "Mena A Carrato" @default.
- Q89243309 P304 "A638" @default.
- Q89243309 P31 Q13442814 @default.
- Q89243309 P356 "10.1016/J.JVAL.2014.08.2298" @default.
- Q89243309 P433 "7" @default.
- Q89243309 P478 "17" @default.
- Q89243309 P577 "2014-10-26T00:00:00Z" @default.
- Q89243309 P698 "27202279" @default.
- Q89243309 P921 Q282142 @default.
- Q89243309 P921 Q413299 @default.
- Q89243309 P921 Q425088 @default.